Testing, testing, testing is the challenge not swiftly answered & What is to be done? @HenryIMiller @PacificResearch
Johnson & Johnson aims to produce 600 million to 900 million doses of its potential coronavirus vaccine by April 2021 if human trials set to begin in September go as planned, J&J executives said Tuesday.